Health news summaries — Page 5
Essential facts and source links for recent health stories.
-
Stroke rates rose among adults under 55 while falling for older adults
A Neurology study of 2,076 first-ever strokes in Greater Cincinnati and Northern Kentucky found rates among adults ages 20–54 rose from 33.9 per 100,000 person-years in 1993–94 to 62.2 in 2020. Rates among older adults fell from 618.8 to 453.0. -
Jonathan Kuo says sleep and recovery are central to nervous-system resilience
Dr. Jonathan Kuo says nervous-system resilience means returning to baseline after stress, not staying calm; his advice is to prioritize sleep, manageable movement, social connection and time outdoors over stacking wellness interventions. -
Establishment Labs raises 2026 revenue guidance after 31.7% quarterly growth
Establishment Labs’ second-quarter revenue rose 31.7% year over year to $67.5 million, while adjusted EBITDA turned positive at $3.7 million from an $8.5 million loss. It raised 2026 revenue guidance to $269 million-$271 million despite an $11.7 million net loss. -
Perdoceo agrees to buy South University, adding 11 campuses
Perdoceo Education agreed to acquire South University, adding 11 campuses and online programs in nursing, pharmacy and physician assistant studies. The deal still needs regulatory and accreditor approvals and could close as early as April 2027. -
Iambic's IPO filing coincides with AbbVie's multi-year AI drug pact
Iambic Therapeutics filed for a U.S. IPO on Sept. 21 and announced a multi-year research pact with AbbVie that day. Its AI platform will design small-molecule programs in immunology, neuroscience and oncology; NVIDIA and Qatar Investment Authority have backed the startup. -
Early retirement requires a health insurance plan before Medicare
Anyone planning to retire before 65 needs to price health coverage before leaving work: Medicare generally starts at 65, and without a spouse’s workplace plan, they may need to buy insurance themselves. Premiums may be much higher than expected and strain a retirement budget. -
Motley Fool puts potential value of Lilly’s retatrutide above $10 billion
The Motley Fool estimates Eli Lilly’s unapproved retatrutide could be worth more than $10 billion to the company, citing Phase 3 weight-loss results and potential use in severe obesity; Lilly plans to submit an approval application in the first quarter of 2027. -
Flu activity in D.C. typically rises in October and peaks in winter
In Washington, D.C., flu activity typically rises in October and peaks in winter; U.S. peaks most often fall in December–February, though timing varies. Symptoms often start suddenly and include fever, cough, sore throat, aches and fatigue.
